About 100ML Mannitol Injection IP
Capitalise on our Promotion and Clearance deals for the 100ML Mannitol Injection IP, an incomparable pharmaceutical solution designed for hospital and clinical use. This majestic, clear, colorless, and sterile liquid is administered exclusively via intravenous infusion as prescribed by a physician. With astonishing efficacy in reducing intracranial and intraocular pressure, its 20% w/v Mannitol formulation acts as a potent osmotic diuretic. Manufactured in India, each product is securely packed in a plastic infusion bottle and boasts a 2-year shelf life for unmatched value.
Clinical Application and User Guidance
100ML Mannitol Injection IP serves as an invaluable osmotic diuretic, specially formulated for intravenous administration in hospitals and clinics. It is used by healthcare professionals on surfaces such as veins or intravenous lines, guided by careful dosing as prescribed for each patient. Its main application is targeted reduction of intracranial and intraocular pressures and the promotion of diuresis in acute renal failure, making it indispensable for critical medical interventions.
Sample Availability, Market Reach, and Packaging Strength
Experience quick dispatch and seamless order completion with our Mannitol Injection IP, now available for sample requests across India's main domestic market. Our institutional pack ensures all expenditure is justified with robust, sterile packaging, guaranteeing product integrity from supplier to healthcare facility. Each pack undergoes meticulous quality control, ensuring every order meets stringent industry standards and is delivered on time for prompt hospital or clinical use.
FAQ's of 100ML Mannitol Injection IP:
Q: How should Mannitol Injection IP 100ML be administered?
A: Mannitol Injection IP 100ML must be administered intravenously at a controlled rate by a qualified medical professional and only as directed by a physician.
Q: What are the main indications for the use of Mannitol Injection IP?
A: This injection is primarily indicated for reducing intracranial and intraocular pressure and for promoting diuresis in acute renal failure.
Q: When is the use of Mannitol Injection IP contraindicated?
A: Mannitol Injection IP should not be used in cases of severe dehydration, established anuria, active intracranial bleeding, or pulmonary edema.
Q: Where can Mannitol Injection IP be purchased and by whom is it marketed?
A: This product is marketed by reputed pharmaceutical companies in India and is generally supplied to hospitals, clinics, and institutional buyers.
Q: What is the process for storing Mannitol Injection 100ML?
A: The injection should be stored below 30C, protected from light, and must not be frozen to ensure product efficacy throughout its shelf life.
Q: What are potential side effects of using Mannitol Injection IP?
A: Possible side effects may include electrolyte imbalance, dehydration, headache, and chest pain; usage should always be monitored by healthcare professionals.